Apotex, a Canadian drugmaker, won approval to make and sell semaglutide in Canada. This adds another manufacturer of the weight-loss drug to the market.

• •Apotex won Canadian approval for semaglutide
• •Adds another semaglutide maker to the Canadian market

Novo Nordisk got approval to sell a weekly diabetes medicine in Japan and China. The drug is designed to be injected once a week instead of more often.

• •Novo Nordisk won approval for a weekly diabetes drug in Japan and China
• •The drug is given as an injection once a week

Canada approved a second generic copy of semaglutide (Ozempic), the diabetes and weight-loss drug. This gives patients more affordable options beyond the original brand-name version.

• •Canada approved a second generic version of semaglutide (Ozempic)
• •The drug treats diabetes and is used for weight loss

Canada approved the first generic version of semaglutide (a diabetes and weight-loss drug) among major wealthy nations. This allows cheaper copies to be sold, potentially making the medication more affordable for Canadian patients.

• •Canada approved the first generic semaglutide in the G7
• •The drug is used for diabetes and weight loss
• •Generic copies could lower prices for Canadian patients

Novo Nordisk's pill version of Ozempic (semaglutide) is now available in the U.S. for type 2 diabetes. This is the oral form of the drug, which was previously only sold as an injection.

• •Novo Nordisk's oral semaglutide is now available in the U.S.
• •The pill is approved for type 2 diabetes
• •Ozempic was previously sold only as an injection

Apotex got approval from Health Canada to sell a generic copy of Ozempic (semaglutide), the popular weight-loss and diabetes drug. Generic versions are cheaper than the brand-name drug, which could help more people afford the medication.

• •Health Canada approved Apotex's generic version of Ozempic (semaglutide)
• •The drug is used for diabetes and weight loss

Orbicular and Apotex won approval from Health Canada to sell a generic copy of semaglutide injection (the active ingredient in Ozempic). This is a cheaper version of the weight-loss and diabetes drug.

• •Health Canada approved a generic semaglutide injection
• •Orbicular partnered with Apotex on the product
• •Generic copies the active ingredient in Ozempic

Apotex, a Canadian drug maker, got approval to sell a generic copy of Ozempic (semaglutide), a popular weight-loss and diabetes drug. Apotex is the first Canadian company to win this approval from Health Canada.

• •Health Canada approved Apotex's generic version of Ozempic (semaglutide)
• •Apotex is the first Canadian company to win this approval
• •The drug is used for weight loss and diabetes

Canada approved a generic version of semaglutide (the active ingredient in Ozempic). This means Canadian patients may have access to a cheaper copy of the weight-loss and diabetes drug.

• •Canada approved a generic version of semaglutide
• •Semaglutide is the active ingredient in Ozempic
• •Generic may give Canadian patients a cheaper option

Dr. Reddy's Laboratories won approval from Health Canada to sell generic semaglutide injections in 2 mg and 4 mg pen versions. This is the first generic version of the popular weight-loss and diabetes drug approved in Canada.

• •Health Canada approved Dr. Reddy's generic semaglutide injection
• •Approval covers 2 mg and 4 mg pen versions
• •First generic semaglutide approved in Canada

Canada approved a second generic copy of semaglutide (the active ingredient in Ozempic). This gives patients more affordable options for the diabetes and weight-loss drug.

• •Canada approved a second generic version of semaglutide
• •Semaglutide is the active ingredient in Novo's Ozempic
• •The drug is used for diabetes and weight loss

Health Canada approved a second generic copy of semaglutide (Ozempic), made by a Canadian company. This gives patients another cheaper option to buy the weight-loss and diabetes drug.

• •Health Canada approved a second generic version of semaglutide (Ozempic)
• •The new generic is made by a Canadian company

Apotex, a Canadian drugmaker, got approval to sell a generic copy of Ozempic (semaglutide), a popular weight-loss and diabetes drug. Apotex is the first Canadian company to win this approval from Health Canada, the country's medicine regulator.

• •Apotex won Health Canada approval for a generic version of Ozempic (semaglutide).
• •Apotex is the first Canadian-based company to get this generic approval.

• •Rhythm Pharmaceuticals received European approval for an obesity drug.
• •Company shares rose on the news.

Novo Nordisk's pill version of Ozempic (semaglutide) is coming to the U.S. market soon. This is the only FDA-approved oral GLP-1 drug for adults with type 2 diabetes.

• •Novo's oral Ozempic (semaglutide) will soon launch in the US
• •It is the only FDA-approved oral GLP-1 pill for adults with type 2 diabetes

Novo Nordisk is preparing to launch the pill version of Ozempic in the U.S. This is a new way to take the weight-loss and diabetes drug that many people currently get as a weekly injection.

• •Novo Nordisk is getting ready to launch a pill version of Ozempic in the US
• •Most people now take Ozempic as a weekly shot

Novo Nordisk said its pill version of Ozempic (semaglutide) will be available in U.S. pharmacies starting May 4. This is the oral form of the diabetes and weight-loss drug that was previously only available as an injection.

• •Novo Nordisk says oral semaglutide Ozempic tablets will hit US pharmacies May 4
• •Pill version covers same diabetes and weight-loss uses as the injection

Canada approved Dr. Reddy's generic copy of semaglutide (Ozempic), Novo Nordisk's weight-loss and diabetes drug. This is the first generic version available in Canada and may lower the cost for patients who need the medication.

• •Canada approved Dr. Reddy's generic version of semaglutide (Ozempic)
• •It is the first generic Ozempic available in Canada
• •Generic could lower cost for diabetes and weight-loss patients

Dr. Reddy's Laboratories got approval from Health Canada to sell a generic copy of semaglutide injection. This is the first generic version of the weight-loss drug allowed in Canada.

• •Health Canada approved Dr. Reddy's generic semaglutide injection
• •First generic semaglutide cleared for sale in Canada

Dr. Reddy's got approval to sell a generic copy of semaglutide (Ozempic), a popular weight-loss drug made by Novo Nordisk. The article says the generic version will cost less than the brand-name drug.

• •Dr. Reddy's got approval to sell a generic version of semaglutide (Ozempic).
• •The generic will cost less than Novo Nordisk's brand-name Ozempic.

Health Canada approved the first generic copy of semaglutide (Ozempic), Novo Nordisk's diabetes and weight-loss drug. Generic versions are usually cheaper than brand-name drugs, so this approval could give more patients affordable access.

• •Health Canada approved the first generic version of semaglutide (Ozempic)
• •Ozempic is Novo Nordisk's diabetes and weight-loss drug
• •Generic copies are usually cheaper than the brand-name drug

Canada approved the first generic copy of semaglutide (Ozempic), the popular weight-loss and diabetes drug made by Novo Nordisk. Generic versions are cheaper alternatives that could increase competition in the growing GLP-1 market.

• •Canada approved the first generic version of semaglutide (Ozempic)
• •Ozempic is made by Novo Nordisk
• •Approval comes amid rising competition in the GLP-1 market

Innovent won approval in China to sell mazdutide, a weight-loss drug that competes with Novo Nordisk and Eli Lilly's products. This is the first major rival to reach the Chinese market for obesity drugs.

• •Innovent won approval in China to sell mazdutide for obesity
• •Mazdutide is described as the first major obesity drug rival in China to Novo and Lilly
• •Novo Nordisk and Eli Lilly are named as the incumbent competitors affected